Bristol-Myers Squibb Annual Report 2023 Form 10-K (NYSE:BMY ...

... 2024, or earlier in certain circumstances. Lawsuits filed by BMS are pending against other companies that filed 505(b)(2) NDA applications ...







BRISTOL-MYERS SQUIBB COMPANY - cloudfront.net
Bristol-Myers Squibb Company has no non-voting common equity. At February 7, 2023, there were 2,098,775,978 shares of common stock outstanding.
ANNUAL REPORT-2024 - MedTherapy Biotech
? The entire facility is integrated with Building Management System (BMS) for continuous online real-time monitoring. ? User requirement specification (URS) ...
united states securities and exchange commission - form 10-k
Such Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the registrant's fiscal ...



Autres Cours:

Annual Report - Bayer